About this trial
The goal of this cross-sectional study is to investigate the prevalence of Exercise Induced Laryngeal Obstruction (EILO) in children with asthma.
The hypothesis is that the prevalence will be around 15%, which is higher than the prevalence of 5-8% among the general adolescent population. This is based on the increased prevalence of EILO among adult asthmatics.
Participants who are referred for an Exercise Challenge Test will perform an additional Continuous Laryngoscopy during Exercise Test with expiratory FEV1 curves, and fill in the Borg scale for dyspnea, Asthma Control Test, EILODI questionnaire and DISCO-RC questionnaire.
Eligibility criteria
Qualifiers
Age 12 to 18 years
Paediatrician diagnosed asthma confirmed with at least one of the following during the last two years: Positive ECT (post-exercise fall in FEV1 > 10%) / Positive methacholine test (PC20 value of ≤8 mg/mL) / Bronchodilator reversibility (increase in FEV1 ≥12% and/or ≥200 mL following inhalation of 200-400 μg short-acting β2-agonists)
Disqualifiers
Other severe cardiopulmonary disease
Inability to perform ECT or CLE test
Inability to perform technically acceptable spirometry
Asthma exacerbation or respiratory tract infection in the last 2 weeks
Trial design
Treatments tested in this trial
- Continuous Laryngoscopy during Exercise Test (CLE test)
Treatment groups
Sponsors and collaborators
Medisch Spectrum Twente
Lead sponsor
Haukeland University Hospital
Collaborator